Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2022-10-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
第五届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's fifth board of directors' second meeting, including approval of the 2022 third quarter report, asset impairment provisions, and a donation by a subsidiary. It includes voting results and references to related disclosures on the official information disclosure website. The document is short (1275 characters) and primarily reports on board meeting decisions rather than containing the full financial report or detailed financial data. It is not the quarterly report itself but an announcement of board resolutions and related approvals. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2022-10-24 Chinese
2022年第二次临时股东大会决议公告（更正后）
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 second extraordinary general meeting of shareholders of Yunnan Watson Biotechnology Co., Ltd. It includes information about the meeting date, attendance, voting results on various board and supervisory committee elections, and legal opinions on the meeting's validity. The content focuses on the voting outcomes and official decisions made during the shareholders' meeting. There is no financial data or report content, but rather the official results of shareholder votes. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4193 characters, which is sufficient to contain detailed voting results rather than a brief announcement. Therefore, the correct classification is DVA with high confidence.
2022-10-14 Chinese
关于2022年第二次临时股东大会决议公告的更正公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a correction announcement regarding the voting results of proposals from the 2022 second extraordinary shareholders meeting of Yunnan Watson Biotechnology Co., Ltd. It specifically corrects the voting data for the election of the fifth board of directors, including non-independent and independent directors. The content focuses on shareholder voting results and corrections to previously disclosed data. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official voting outcomes and corrections related to a shareholders meeting. The document length is short (2004 characters) and it contains detailed voting results, not just a notice or link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the classification is DVA with high confidence.
2022-10-14 Chinese
第五届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the fifth board of directors of Yunnan Walvax Biotechnology Co., Ltd. It includes election and appointment of the chairman, vice chairman, president, board secretary, audit responsible person, other senior management, and securities affairs representative. It also lists the composition of board committees and provides biographies of the appointed individuals. The document is focused on changes and appointments in the company's board and senior management, with voting results and compliance statements. There is no financial data, earnings information, or report publication notice. The content clearly fits the category of Board/Management Information (MANG).
2022-10-13 Chinese
关于监事会完成换届选举暨部分监事变更的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about the completion of the supervisory board re-election and changes in some supervisors. It details the election of a new supervisor, the composition of the supervisory board, and the departure of a previous supervisor. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings release, and no regulatory filings related to financial performance. The content focuses on changes in the supervisory board members, which falls under management or board information. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct announcement of board changes.
2022-10-13 Chinese
2022年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2022 second extraordinary general meeting of shareholders of Yunnan Watson Biotechnology Co., Ltd. It includes information about the meeting date, attendance, voting results on various board and supervisory committee elections, and legal opinions on the meeting's validity. The content focuses on shareholder voting outcomes and board member appointments, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements. The document length is 4187 characters, which is sufficient to contain substantive voting results rather than just a brief announcement or a report publication notice. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2022-10-13 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.